Search Results for 'cirrhosis treatment'

cirrhosis treatment published presentations and documents on DocSlides.

Cirrhosis and complications
Cirrhosis and complications
by conchita-marotz
Best of ILC 2018. About these slides. These slide...
Liver Cirrhosis
Liver Cirrhosis
by giovanna-bartolotta
KNH 411. Morgan . Deihs. Lydia Dysart. Objectives...
HBV related cirrhosis Geoff Dusheiko
HBV related cirrhosis Geoff Dusheiko
by maxasp
Kings College Hospital London UK. . 20–50%. . ...
MM: HCV and Cirrhosis Patient Case
MM: HCV and Cirrhosis Patient Case
by devin732
Chris Kolkman. PrimaryOne. Health. Meet MM. Patie...
Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir
Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir
by pamella-moone
SIRIUS. Phase . 2 . Treatment. . Experienced. Bo...
Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
by badra
Duke University School of Medicine. Durham, North ...
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
by hezekiah
FALDAPREVIR (BI 201335) + BI 207127 ± RIBAVIRIN. ...
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
by della
Kristen M. Marks, MD. Assistant Professor. Weill C...
HCV 2016  Alex Rodgers Hepatologist
HCV 2016 Alex Rodgers Hepatologist
by radions
. FMC. Disclosures. nil. Learning objectives/. t. ...
CRONIC HEPATITIS, CIRRHOSIS, HEPATIC FAILURE
CRONIC HEPATITIS, CIRRHOSIS, HEPATIC FAILURE
by tawny-fly
ASSOC. PROF. DR. INGRID MIRON. What is Viral Hepa...
Treatment regimens
Treatment regimens
by mitsue-stanley
Co-formulated . ombitasvir. (OBV)/. paritaprevir...
Treatment regimens
Treatment regimens
by natalia-silvester
Co-formulated . ombitasvir. (OBV)/. paritaprevir...
Mazen Hassanain Portal Hypertension
Mazen Hassanain Portal Hypertension
by escapistlego
Causes. Cirrhosis. Non-cirrhosis. Symptoms. Asympt...
Cirrhosis and complications Best of ILC 2018 About
Cirrhosis and complications Best of ILC 2018 About
by alexa-scheidler
Cirrhosis and complications Best of ILC 2018 About...
Insight into the  history
Insight into the history
by elizabeth
of hepatitis C virus (HCV. ) infection; . a cohort...
COMPLICATIONS OF LIVER CIRRHOSIS
COMPLICATIONS OF LIVER CIRRHOSIS
by elyana
DR. SANJANA BHAGWAT. MODERATOR : DR. SHIMPA SHARMA...
Ascites and  Hepatocellular carcinoma
Ascites and Hepatocellular carcinoma
by jocelyn
Curtis Barry, MD. UMASS ECHO. April 21, 2017. Asci...
Hepatocellular Carcinoma in the Absence of Cirrhosis
Hepatocellular Carcinoma in the Absence of Cirrhosis
by pinperc
Richa Shukla. Faculty mentor: Dr. Sahil Mittal. Fe...
Efficacy and Safety of
Efficacy and Safety of
by olivia-moreira
Efficacy and Safety of Glecaprevir / Pibrentasvi...
Dr. Ravi  kant   Assistant Professor Department of General Medicine
Dr. Ravi kant Assistant Professor Department of General Medicine
by briana-ranney
Dr. Ravi kant Assistant Professor Department o...
Hepatitis C Imtiaz Alam, M.D.
Hepatitis C Imtiaz Alam, M.D.
by olivia-moreira
Medical Director, Austin Hepatitis Center. 1. Hep...
Hepatocellular Carcinoma in the Absence of Cirrhosis
Hepatocellular Carcinoma in the Absence of Cirrhosis
by olivia-moreira
Richa Shukla. Faculty mentor: Dr. Sahil Mittal. F...
Alcoholic Liver Disease Directed Readings
Alcoholic Liver Disease Directed Readings
by min-jolicoeur
In the Classroom. July/August 2013 issue of . Rad...
No  randomisation
No randomisation
by tatiana-dople
N = 100. W12. W24. Arm B: . compensated cirrhosis...
Treatment of Hepatitis C in Primary Care
Treatment of Hepatitis C in Primary Care
by belinda
Jocelyn James, MD. Assistant Professor, Department...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by danika-pritchard
IAPAC African Regional Capacity-Building Hub. Bas...
Taking Steps to Improve the Management
Taking Steps to Improve the Management
by mitsue-stanley
of Chronic HCV. This educational program and spea...
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
by kittie-lecroy
Interim Analysis of a French Multicenter Compassi...
Updates in Treatment of Hepatitis C
Updates in Treatment of Hepatitis C
by myesha-ticknor
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Description of Antivirals for Hepatitis C
Description of Antivirals for Hepatitis C
by conchita-marotz
LCDR Dwayne David, . PharmD. , BCPS, NCPS. Cherok...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by trish-goza
IAPAC African Regional Capacity-Building Hub. Bas...
Slides for today’s webinar are available on the CIHS website at:
Slides for today’s webinar are available on the CIHS website at:
by tatiana-dople
Slides for today’s webinar are available on the...
Approach to patient with ascites
Approach to patient with ascites
by byrne
Ameen . mahmoud. Layan al-. hamdan. Diana...
Treatment of Chronic HCV
Treatment of Chronic HCV
by lam
with Direct-Acting Antivirals (DAAs). www.hcvguide...
Diagnosis  Management of Viral Hepatitis
Diagnosis Management of Viral Hepatitis
by eddey
National Guidelines for Diagnosis & Management of ...
Hepatitis C in PWIDS London:
Hepatitis C in PWIDS London:
by obrien
PARTNERSHIP TOWARDS ELIMINATION OF A MAJOR PUBLIC ...
Pretreatment Assessment in Adults With Chronic Hepatitis C Virus Infection
Pretreatment Assessment in Adults With Chronic Hepatitis C Virus Infection
by porter
www.hivguidelines.org. OCTOBER 2022. NYSDOH AIDS I...
Chronic hepatitis C: guidelines for screening and
Chronic hepatitis C: guidelines for screening and
by aaron
treatment. Lisa M. Glass, MD. Clinical Lecturer. ...
Updates in Treatment of Hepatitis C
Updates in Treatment of Hepatitis C
by cheryl-pisano
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Daclatasvir
Daclatasvir
by tatyana-admore
. + . Sofosbuvir. in Genotype . 3. ALLY-3 Study...